Cite
HARVARD Citation
Reichel, F. et al. (2022). Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial. British journal of ophthalmology. 106 (11), pp. 1567-1572. [Online].